Ribavirin shows promising effects against cancer via suppressing eIF4E phosphorylation and activation and leading to decreased mRNA export and protein synthesis in pharyngeal, ovarian, breast cancer, acute lymphoblastic leukemia (ALL), osteosarcoma, and glioma [187,188,189,190,191,192,193,194]. Here, EIF4E is linked to acute lymphoblastic leukemia.